News

Updates from NHS BSA, MHRA drug safety alerts, and other medical news.

MHRA Alert – Semaglutide and Risk of Vision Loss (NAION)

Safety Alert: Semaglutide and Non-arteritic Anterior Ischemic Optic Neuropathy The MHRA has issued a safety update regarding a very rare but serious risk associated with semaglutide-containing medicines. Clinicians and responders should be aware of this potential adverse effect, particularly when counselling patients or assessing vision-related complaints. What is NAION? Non-arteritic anterior ischemic optic neuropathy (NAION) […]